Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07396064

Bridging the Gap: Enhancing Cancer Care for Underserved Populations With the Veris Health Cancer Care Platform

The proposed study aims to optimize and validate the Veris Cancer Care Platform for the needs of medically underserved cancer patients receiving outpatient cancer therapy. The Veris Health platform is a remote patient monitoring and communication system designed to bridge the gap between clinical visits and provide oncology care teams with objective data during high-risk periods.

This study will specifically focus on optimizing the Veris Health platform for patients with language barriers, limited access to technology, and socioeconomic disparities. By incorporating user-centered design and working closely with community health centers, the research team will ensure that the platform is culturally and linguistically appropriate, easy to use, and accessible for all patients.

The study will use a mixed-methods approach to validate the effectiveness of the optimized platform, including quantitative data analysis and qualitative interviews with patients and healthcare providers. The goal is to demonstrate the potential for the Veris Health platform to improve outcomes for vulnerable populations by reducing hospitalizations, emergency department visits, and the economic burden of cancer care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cancer Care Recipient Observational Study

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults > 18 years old
  • Diagnosis of cancer
  • ECOG Performance Status of 0-2
  • Undergoing or initiating systemic anticancer therapy
  • Able to utilize and interact with a mobile application and in-home devices for physiological monitoring. Have at least one of the following barriers to healthcare access: Spanish as primary language, uninsured, insured with Medicaid, dual eligible for Medicare and Medicaid

Exclusion criteria

-N/A

Treatment and study plan

Veris Health Inc. Application

Other

Veris Health offers at-home devices to monitor multiple physiological parameters, including temperature, heart rate, oxygen saturation, blood pressure, weight, and activity (step count). Patients are provided with a home cellular hub that is already paired to peripheral devices via Bluetooth. The hub communicates with all devices and the local cellular network out-of-the-box, and data is automatically sent via cellular network to the Veris Health backend database, making it easy for patients to use the system. Patients are responsible for taking their vital sign measurements daily. The devices automatically send the measurement data to the Veris Health HIPAA compliant, secure cloud server via the preconnected cellular hub.

Primary outcomes

  1. Usability of the Veris Health Cancer Care Platform

    Time frame: 5 Months

    Usability of the Veris Health Cancer Care platform as assessed by the Software Usability Measurement Inventory (SUMI) among patients, caretakers, and healthcare teams.

    Measure: SUMI total and domain scores

    Time Frame: During study participation

  2. Product Design Usability and Acceptability

    Time frame: 5 Months

    Ease of use, accessibility, and acceptability of the Veris Health Cancer Care platform based on A/B testing of product design features.

    Measure: Comparative usability metrics (e.g., task completion success, user preference)

    Time Frame: During study participation

  3. User Needs and Preferences

    Time frame: 5 Months

    User-identified needs, preferences, and barriers to use of the Veris Health Cancer Care platform.

    Measure: Qualitative themes derived from user interviews and focus groups

    Time Frame: During study participation

Secondary outcomes

  1. Health-Related Quality of Life (HRQL)

    Time frame: 5 Months

    Change in health-related quality of life among participants using the Veris Health Cancer Care platform.

    Measure: EQ-5D Index score

  2. Symptom Burden of Cancer Treatment Side Effects

    Time frame: 5 Months

    Frequency and severity of cancer treatment-related symptoms, including nausea, diarrhea, and infection.

    Measure: Patient-reported symptom frequency and severity scores

  3. Cancer Treatment Adherence and Duration

    Time frame: 5 months

    Adherence to prescribed cancer therapy and treatment duration.

    Measure: Rates of dose reductions, early treatment discontinuation, and treatment duration

Study contacts

Contact information is provided by the study sponsor or research team.

Brian deGuzman MD COO

CONTACT

[email protected]

917-813-1828

Sponsors and collaborators

Lead sponsor

VERIS HEALTH INC

Industry

Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)
  • National Institutes of Health (NIH)

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 9, 2026
Registry last updated
Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.